New hope for controlling rare inflammatory disease
NCT ID NCT07203001
Summary
This study is testing an experimental drug called MAS825 in adults and children with Still's disease, a rare inflammatory condition. The main goal is to see if MAS825 can effectively control disease activity and reduce the need for steroid medications. Researchers will also monitor the drug's safety and how it affects patients' quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STILL´S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Cincinnati Childrens Hospital
RECRUITINGCincinnati, Ohio, 45229, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Legacy Emanuel Research Hosp Portland
RECRUITINGPortland, Oregon, 97232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Novartis Investigative Site
RECRUITINGMontreal, Quebec, H3T 1C5, Canada
-
Novartis Investigative Site
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
Novartis Investigative Site
RECRUITINGBordeaux, 33076, France
-
Novartis Investigative Site
RECRUITINGLe Kremlin-Bicêtre, 94275, France
-
Novartis Investigative Site
RECRUITINGLille, 59037, France
-
Novartis Investigative Site
RECRUITINGParis, 75015, France
-
Novartis Investigative Site
RECRUITINGParis, 75970, France
-
Novartis Investigative Site
RECRUITINGSankt Augustin, North Rhine-Westphalia, 53757, Germany
-
Novartis Investigative Site
RECRUITINGMünster, 48149, Germany
-
Novartis Investigative Site
RECRUITINGFlorence, FI, 50139, Italy
-
Novartis Investigative Site
RECRUITINGGenova, GE, 16147, Italy
-
Novartis Investigative Site
RECRUITINGRoma, RM, 00165, Italy
-
Novartis Investigative Site
RECRUITINGUtrecht, 3584 CX, Netherlands
-
Novartis Investigative Site
RECRUITINGEsplugues, Barcelona, 08950, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28046, Spain
-
Novartis Investigative Site
RECRUITINGValencia, 46026, Spain
-
Novartis Investigative Site
RECRUITINGIstanbul, Fatih, 34098, Turkey (Türkiye)
-
Novartis Investigative Site
RECRUITINGAnkara, Sihhiye-Altindag, 06230, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.